Filing Details

Accession Number:
0001288123-10-000005
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-01-21 12:00:00
Reporting Period:
2010-01-19
Filing Date:
2010-01-21
Accepted Time:
2010-01-21 11:17:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1098972 Antigenics Inc AGEN Biological Products, (No Disgnostic Substances) (2836) 061562417
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1288123 M Christine Klaskin 162 Fifth Ave., Suite 900
New York NY 10010
Vp, Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-01-19 78,868 $0.90 148,356 No 4 A Direct
Common Stock Acquisiton 2010-01-20 78,868 $0.85 69,488 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 195 Indirect by husband
Footnotes
  1. Represents settlement of restricted stock granted on January 19, 2010 in lieu of an annual cash bonus for 2009 performance.
  2. Represents the sale of shares obtained from the vesting of restricted stock granted on January 19, 2010 in lieu of an annual cash bonus for 2009 performance. This sale has been made through a Rule 10b5-1 trading plan.